Corpora amylacea are associated with tau burden and cognitive status in Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Corpora amylacea are associated with tau burden and cognitive status in Alzheimer’s disease ; volume:10 ; number:1 ; day:8 ; month:8 ; year:2022 ; pages:1-17 ; date:12.2022
Acta Neuropathologica Communications ; 10, Heft 1 (8.8.2022), 1-17, 12.2022

Creator: Wander, Connor M.
Tsujimoto, Tamy Harumy Moraes
Ervin, John F.
Wang, Chanung
Maranto, Spencer M.
Bhat, Vanya
Dallmeier, Julian D.
Wang, Shih-Hsiu Jerry
Lin, Feng-Chang
Scott, William K.
Holtzman, David M.
Cohen, Todd J.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-022-01409-5

URN: urn:nbn:de:101:1-2022102422193659869954

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wander, Connor M.
Tsujimoto, Tamy Harumy Moraes
Ervin, John F.
Wang, Chanung
Maranto, Spencer M.
Bhat, Vanya
Dallmeier, Julian D.
Wang, Shih-Hsiu Jerry
Lin, Feng-Chang
Scott, William K.
Holtzman, David M.
Cohen, Todd J.
SpringerLink (Online service)

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Will cognitive mapping hinder Alzheimer’s Disease?

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Will cognitive mapping hinder Alzheimer’s Disease?

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Will cognitive mapping hinder Alzheimer’s Disease?

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Corpora amylacea are associated with tau burden and cognitive status in Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Will cognitive mapping hinder Alzheimer’s Disease?

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Will cognitive mapping hinder Alzheimer’s Disease?

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Will cognitive mapping hinder Alzheimer’s Disease?

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Related objects

Reset password